"The analysis and identification of signatures for the initial infection is always behind the threat becoming known and out in the wild," says Matt Walmsley, EMEA director at Vectra. "It’s not enough to build stronger defenses. Motivated and well-resourced attackers will always find a way given enough time and persistence."

Read the article